A variety of benign lesions affecting the pleura and/or lung can result from inhaling asbestos fibers. Establishing the presence or absence of these entities often plays an important role in the evaluation, presentation and ultimate resolution of asbestos disease litigation. Forensic pathologists may become involved in these cases to address issues of diagnosis, exposure and/or disease attribution. This article reviews medicolegal issues pertaining to benign asbestos-induced diseases of the pleura and lung.
GrahamM.A.RoggliV.L.. Medicolegal aspects of asbestos—malignant mesothelioma and lung cancer.Acad Forensic Pathol.2013 Dec; 3(4): pp.
2.
MarchandF.. Ueber eigenttimliche pigmentkristalle in den lungen.Verhandl d’ Deutsch path gesellsch.190610: 223–8. German.
3.
FahrT.. Demonstrationen: Praparate und microphotogrammes von einen falle von pneumokoniose.Muench Med Woch.1914; 11: 625. German.
4.
StewartM.J.HaddowA.C.. Demonstration of the peculiar bodies of pulmonary asbestosis (“asbestosis bodies”) in material obtained by lung puncture and in the sputum.J Pathol Bact.1929; 32: 172.
5.
ChurgA.M.WarnockM.L.. Asbestos and other ferruginous bodies: their formation and clinical significance.Am J Pathol.1981 Mar; 102(3): 447–56.
6.
ChurgA.WarnockM.L.. Analysis of the cores of ferruginous (asbestos) bodies from the general population. I. Patients with and without lung cancer.Lab Invest.1977 Sep; 37(3): 280–6.
7.
ChurgA.WarnockM.L.GreenN.. Analysis of the cores of ferruginous (asbestos) bodies from the general population. II. True asbestos bodies and pseudoasbestos bodies.Lab Invest.1979 Jan; 40(1): 31–8.
8.
CrouchE.ChurgA.. Ferruginous bodies and the histologic evaluation of dust exposure.Am J Surg Pathol.1984 Feb; 8(2): 109–16.
9.
HoldenJ.ChurgA.. Asbestos bodies and the diagnosis of asbestosis in chrysotile workers.Environ Res.1986 Feb; 39(1): 232–6.
10.
RoggliV.L.. Microprobe analysis in medicine.Washington: Hemisphere Pub. Corp.; c1989. Chapter 5, Scanning electron microscopic analysis of mineral fibers in human lungs; p. 97–110.
11.
RoggliV.L.BrodyA.R.. Imaging techniques for application to lung toxicology. In: GardnerD.E.CrapoJ.D.MassaroE.J., editors. Toxicology of the lung.New York: Raven Press; 1988. p. 117–45.
12.
ChurgA.M.WarnockM.L.. Analysis of cores of ferruginous (asbestos) bodies from the general population. III. Patients with environmental exposure.Lab Invest.1979 May; 40(5): 622–6.
13.
RoggliV.L.PrattP.C.BrodyA.R.. Asbestos content of lung tissue in asbestos associated diseases: a study of 110 cases.Br J Ind Med.1986 Jan; 43(1): 18–28.
14.
DodsonR.F.WilliamsM.G.Jr.HurstG.A.. Method for removing the ferruginous coating from asbestos bodies.J Toxicol Environ Health.1983 Apr-Jun; 11(4–6): 959–66.
15.
SuzukiY.ChurgJ.. Structure and development of the asbestos body.Am J Pathol.1969 Apr; 55(1): 79–107.
16.
MorganA.HolmesA.. The enigmatic asbestos body: its formation and significance in asbestos-related disease.Environ Res.1985 Dec; 38(2): 283–92.
17.
DavisJ.M.. Further observations on the ultrastructure and chemistry of the formation of asbestos bodies.Exp Mol Pathol.1970 Dec; 13(3): 346–58.
18.
HaqueA.K.KanzM.F.. Asbestos bodies in children's lungs. An association with sudden infant death syndrome and bronchopulmonary dysplasia.Arch Pathol Lab Med.1988 May; 112(5): 514–8.
19.
Asbestos bodies and nonasbestos ferruginous bodies. In: RoggliV.L.OuryT.D.SpornT.A., editors. Pathology of asbestos-associated diseases.2nd ed.New York: Springer; 2004. p. 40.
20.
PooleyF.D.RansonD.L.. Comparison of the results of asbestos fibre dust counts in lung tissue obtained by analytical electron microscopy and light microscopy.J Clin Pathol.1986 Mar; 39(3): 313–7.
21.
MorganA.HolmesA.. Distribution and characteristics of amphibole asbestos fibres, measured with the light microscope, in the left lung of an insulation worker.Br J Ind Med.1983 Feb; 40(1): 45–50.
22.
MorganA.HolmesA.. The distribution and characteristics of asbestos fibers in the lungs of Finnish anthophyllite mine-workers.Environ Res.1984 Feb; 33(1): 62–75.
23.
Asbestos bodies and nonasbestos ferruginous bodies. In: RoggliV.L.OuryT.D.SpornT.A., editors. Pathology of asbestos-associated diseases.2nd ed.New York: Springer; 2004. p. 46.
24.
RoggliV.L.PrattP.C.. Numbers of asbestos bodies on iron-stained tissue sections in relation to asbestos body counts in lung tissue digests.Hum Pathol.1983 Apr; 14(4): 355–61.
25.
RoggliV.L.SharmaA.ButnorK.J.. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases.Ultrastruct Pathol.2002 Mar-Apr; 26(2): 55–65.
26.
SteeleR.H.ThomsonK.J.. Asbestos bodies in the lung: Southampton (UK) and Wellington (New Zealand).Br J Ind Med.1982 Nov; 39(4): 349–54.
27.
RogersA.J.. Determination of mineral fibre in human lung tissue by light microscopy and transmission electron microscopy.Ann Occup Hyg.1984; 28(1): 1–12.
28.
KobayashiH.WatanabeH.ZhangW.M.OhnishiY.. A quantitative and histological study of pulmonary effects of asbestos exposure in general autopsied lungs.Acta Pathol Jpn.1986 Dec; 36(12): 1781–91.
29.
De VuystP.KarjalainenA.DumortierP.. Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. European Respiratory Society.Eur Respir J.1998 Jun; 11(6): 1416–26.
30.
AshcroftT.HepplestonA.G.. The optical and electron microscopic determination of pulmonary asbestos fibre concentration and its relation to the human pathological reaction.J Clin Pathol.1973 Mar; 26(3): 224–34.
31.
RoggliV.L.GibbsA.R.AttanoosR.. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society.Arch Pathol Lab Med.2010 Mar; 134(3): 462–80.
32.
KarjalainenA.. editor. Final report: Measurement and Testing Programme Project MAT1-CT94–0072—Reference materials for the analysis of asbestos fibres in lung tissue.Helsinki: Finnish Institute of Occupational Health; 1996.
SahnS.A.AntonyV.B.. Pathogenesis of pleural plaques. Relationship of early cellular response and pathology.Am Rev Respir Dis.1984 Nov; 130(5): 884–7.
35.
ErnstP.ZejdaJ.. Mineral fibers and Health.Boca Raton: CRC Press; c1991. Chapter 10, Pleural and airway disease associated with mineral fibers; p. 121–34.
36.
EplerG.R.McLoudT.C.GaenslerE.A.. Prevalence and incidence of benign asbestos pleural effusion in a working population.JAMA.1982 Feb 5; 247(5): 617–22.
37.
LilisR.LermanY.SelikoffI.J.. Symptomatic benign pleural effusions among asbestos insulation workers: residual radiographic abnormalities.Br J Ind Med.1988 Jul; 45(7): 443–9.
38.
HillerdalG.. Nonmalignant pleural disease related to asbestos exposure.Clin Chest Med.1985 Mar; 6(1): 141–52.
39.
American Thoracic Society.Diagnosis and initial management of nonmalignant diseases related to asbestos.Am J Respir Crit Care Med.2004 Sep 15; 170(6): 691–715.
40.
LarsonT.C.MeyerC.A.KapilV.. Workers with Libby amphibole exposure: retrospective identification and progression of radiographic changes.Radiology.2010 Jun; 255(3): 924–33.
41.
RohlA.N.. Asbestos in talc.Environ Health Perspect.1974 Dec; 9: 129–32.
42.
WeillD.DhillonG.FreyderL.. Lung function, radiological changes and exposure: analysis of ATSDR data from Libby, MT, USA.Eur Respir J.2011 Aug; 38(2): 376–83.
43.
AntaoV.C.LarsonT.C.HortonD.K.. Libby vermiculite exposure and risk of developing asbestos-related lung and pleural diseases.Curr Opin Pulm Med.2012 Mar; 18(2): 161–7.
44.
WainS.L.RoggliV.L.FosterW.L.Jr.. Parietal pleural plaques, asbestos bodies, and neoplasia. A clinical, pathologic, and roentgenographic correlation of 25 consecutive cases.Chest.1984 Nov; 86(5): 707–13.
45.
al JaradN.PoulakisN.PearsonM.C.. Assessment of asbestos-induced pleural disease by computed tomography–correlation with chest radiograph and lung function.Respir Med.1991 May; 85(3): 203–8.
46.
MillerJ.A.ZurloJ.V.. Asbestos plaques in a typical Veteran's hospital population.Am J Ind Med.1996 Dec; 30(6): 726–9.
47.
JeebunV.StentonS.C.. The presentation and natural history of asbestos-induced diffuse pleural thickening.Occup Med (Lond).2012 Jun; 62(4): 266–8.
48.
EplerG.R.McLoudT.C.GaenslerE.A.. Normal chest roentgenograms in chronic diffuse infiltrative lung disease.N Engl J Med.1978 Apr 27; 298(17): 934–9.
49.
KipenH.M.LilisR.SuzukiY.. Pulmonary fibrosis in asbestos insulation workers with lung cancer: a radiological and histopathological evaluation.Br J Ind Med.1987 Feb; 44(2): 96–100.
50.
ChurgA.. Pathology of occupational lung disease.2nd ed.Baltimore: Williams and Wilkins; c1998. Chapter 9, Nonneoplastic diseases caused by asbestos; p. 310.
51.
Chung-ParkM.TomashefskiJ.F.Jr.CohenA.M.. Shrinking pleuritis with lobar atelectasis: a morphologic variant of “round atelectasis.”Hum Pathol.1989 Apr; 20(4): 382–7.
52.
CookeW.E.. Pulmonary asbestosis.Br Med J.1927 Dec 3; 2(3491): 1024–5.
53.
ChurgA.WrightJ.L.DePaoliL.WiggsB.. Mineralogic correlates of fibrosis in chrysotile miners and millers.Am Rev Respir Dis.1989 Apr; 139(4): 891–6.
54.
ChurgA.WrightJ.WiggsB.DepaoliL.. Mineralogic parameters related to amosite asbestos-induced fibrosis in humans.Am Rev Respir Dis.1990 Dec; 142(6 Pt 1): 1331–6.
55.
GreenF.H.HarleyR.VallyathanV.. Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers.Occup Environ Med.1997 Aug; 54(8): 549–59.
56.
GoffA.M.GaenslerE.A.. Asbestosis following brief exposure in cigarette filter manufacture.Respiration.1972; 29(1): 83–93.
57.
QuinlanT.R.MarshJ.P.JanssenY.M.. Dose responsive increases in pulmonary fibrosis after inhalation of asbestos.Am J Respir Crit Care Med.1994 Jul; 150(1): 200–6.
58.
QuinlanT.R.BéruBéK.A.MarshJ.P.. Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos.Am J Pathol.1995 Sep; 147(3): 728–39.
59.
MossmanB.T.ChurgA.. Mechanisms in the pathogenesis of asbestosis and silicosis.Am J Respir Crit Care Med.1998 May; 157(5 Pt 1): 1666–80.
60.
LiuG.ChereshP.KampD.W.. Molecular basis of asbestos-induced lung disease.Annu Rev Pathol.2013 Jan 24; 8: 161–87.
61.
RoggliV.L.. Pathology of human asbestosis: a critical review. In: Advances in pathology (Vol. 2). Chicago: Year Book Med. Pub.; 1989. p. 31–60.
62.
O'ReillyK.M.McLaughlinA.M.BeckettW.S.SimeP.J.. Asbestos-related lung disease.Am Fam Physician.2007 Mar 1; 75(5): 683–8.
63.
RossR.M.. The clinical diagnosis of asbestosis in this century requires more than a chest radiograph.Chest.2003 Sep; 124(3): 1120–8.
64.
American Thoracic Society.Medical Section of the American Lung Association: The diagnosis of nonmalignant diseases related to asbestos.Am Rev Respir Dis.1986 Aug; 134(2): 363–8.
65.
American Thoracic Society.Diagnosis and initial management of nonmalignant diseases related to asbestos.Am J Respir Crit Care Med.2004 Sep 15; 170(6): 691–715.
66.
MizellK.N.MorrisC.G.CarterJ.E.. Antemortem diagnosis of asbestosis by screening chest radiograph correlated with postmortem histologic features of asbestosis: a study of 273 cases.J Occup Med Toxicol.2009 Jun 12; 4: 14.
67.
AkiraM.YamamotoS.InoueY.SakataniM.. High Resolution CT of asbestosis and idiopathic pulmonary fibrosis.AJR Am J Roentgenol.2003 Jul; 181(1): 163–9.
68.
CopleyS.J.WellsA.U.SivakumaranP.. Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features.Radiology.2003 Dec; 229(3): 731–6.
69.
StaplesC.A.GamsuG.RayC.S.WebbW.R.. High resolution computed tomography and lung function in asbestos-exposed workers with normal chest radiographs.Am Rev Respir Dis.1989 Jun; 139(6): 1502–8.
70.
GevenoisP.A.De VuystP.DedeireS.. Conventional and high resolution CT in asymptomatic asbestos-exposed workers.Acta Radiol.1994 May; 35(3): 226–9.
71.
CraigheadJ.E.AbrahamJ.L.ChurgA.. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health.Arch Pathol Lab Med.1982 Oct 8; 106(11): 544–96.
72.
AuerbachO.GarfinkelL.HammondE.C.. Relation of smoking and age to findings in lung parenchyma: a microscopic study.Chest.1974 Jan; 65(1): 29–35.
73.
SchneiderF.SpornT.A.RoggliV.L.. Asbestos fiber content of lungs with diffuse interstitial fibrosis: An analytical scanning electron microscopic analysis of 249 cases.Arch Pathol Lab Med.2010 Mar; 134(3): 457–61.
74.
RoggliV.L.PrattP.C.BrodyA.R.. Pathology of asbestos-associated diseases.Boston: Little, Brown and Co.; c1992. Chapter 11, Analysis of tissue mineral fiber content; p. 299–345.
75.
HnizdoE.Sluis-CremerG.K.. Effect of tobacco smoking on the presence of asbestosis at postmortem and on the reading of irregular opacities on roentgenograms in asbestos-exposed workers.Am Rev Respir Dis.1988 Nov; 138(5): 1207–12.
76.
CottinV.NunesH.BrilletP.Y.. Combined pulmonary fibrosis and emphysema: a distinct under recognised entity.Eur Respir J.2005 Oct; 26(4): 586–93.
